These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38253438)

  • 41. Pepfar 3.0's HIV testing policy in Côte d'Ivoire (2014 to 2018): fragmentation, acceleration and disconnection.
    Bekelynck A; Larmarange J;
    J Int AIDS Soc; 2019 Dec; 22(12):e25424. PubMed ID: 31854504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Think global, act local: the experience of Global Fund and PEPFAR joint cascade assessments to harmonize and strengthen key population HIV programmes in eight countries.
    Lillie TA; Baer J; Adams D; Zhao J; Wolf RC
    J Int AIDS Soc; 2018 Jul; 21 Suppl 5(Suppl Suppl 5):e25125. PubMed ID: 30033537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restrictions On US Global Health Assistance Reduce Key Health Services In Supported Countries.
    Sherwood J; Roemer M; Honermann B; Jones A; Millett G; Decker MR
    Health Aff (Millwood); 2020 Sep; 39(9):1557-1565. PubMed ID: 32897794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries.
    Lane J; Verani A; Hijazi M; Hurley E; Hagopian A; Judice N; MacInnis R; Sanford S; Zelek S; Katz A
    PLoS One; 2016; 11(2):e0146720. PubMed ID: 26914708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Availability of essential drugs for managing HIV-related pain and symptoms within 120 PEPFAR-funded health facilities in East Africa: a cross-sectional survey with onsite verification.
    Harding R; Simms V; Penfold S; Downing J; Powell RA; Mwangi-Powell F; Namisango E; Moreland S; Gikaara N; Atieno M; Kataike J; Nsubuga C; Munene G; Banga G; Higginson IJ
    Palliat Med; 2014 Apr; 28(4):293-301. PubMed ID: 23885009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.
    Goosby E; Dybul M; Fauci AS; Fu J; Walsh T; Needle R; Bouey P
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S51-6. PubMed ID: 22797740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of the US president's emergency plan for AIDS relief (PEPFAR) HIV and AIDS program on the Nigerian health system.
    Odekunle FF; Odekunle RO
    Pan Afr Med J; 2016; 25():143. PubMed ID: 28292105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving the Quality of Voluntary Medical Male Circumcision through Use of the Continuous Quality Improvement Approach: A Pilot in 30 PEPFAR-Supported Sites in Uganda.
    Byabagambi J; Marks P; Megere H; Karamagi E; Byakika S; Opio A; Calnan J; Njeuhmeli E
    PLoS One; 2015; 10(7):e0133369. PubMed ID: 26207986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing the relevance, efficiency, and sustainability of HIV/AIDS in-service training in Nigeria.
    Burlew R; Puckett A; Bailey R; Caffrey M; Brantley S
    Hum Resour Health; 2014 Apr; 12():20. PubMed ID: 24739511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is there an association between PEPFAR funding and improvement in national health indicators in Africa? A retrospective study.
    Duber HC; Coates TJ; Szekeras G; Kaji AH; Lewis RJ
    J Int AIDS Soc; 2010 Jun; 13():21. PubMed ID: 20540795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries' Budgeted Funds, 2004-14.
    Moucheraud C; Sparkes S; Nakamura Y; Gage A; Atun R; Bossert TJ
    Health Aff (Millwood); 2016 May; 35(5):847-55. PubMed ID: 27140991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unsuppressed viral load after intensive adherence counselling in rural eastern Uganda; a case of Kamuli district, Uganda.
    Ndikabona G; Alege JB; Kirirabwa NS; Kimuli D
    BMC Public Health; 2021 Dec; 21(1):2294. PubMed ID: 34922502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PEPFAR support for the scaling up of collaborative TB/HIV activities.
    Howard AA; Gasana M; Getahun H; Harries A; Lawn SD; Miller B; Nelson L; Sitienei J; Coggin WL
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3(0 3):S136-44. PubMed ID: 22797735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scale-Up of HIV Antiretroviral Therapy and Estimation of Averted Infections and HIV-Related Deaths - Uganda, 2004-2022.
    Dirlikov E; Kamoga J; Talisuna SA; Namusobya J; Kasozi DE; Akao J; Birabwa E; Ward JA; Elur B; Shiraishi RW; Corcoran C; Vasireddy V; Nelson R; Nelson LJ; Borgman M; Magongo EN; Kisaakye LN; Katureebe C; Kirungi W; Musinguzi J;
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(4):90-94. PubMed ID: 36701255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding HIV-infected patients' experiences with PEPFAR-associated transitions at a Centre of Excellence in KwaZulu Natal, South Africa: a qualitative study.
    Katz IT; Bogart LM; Cloete C; Crankshaw TL; Giddy J; Govender T; Gaynes MR; Leone D; Losina E; Bassett IV
    AIDS Care; 2015; 27(10):1298-303. PubMed ID: 26300297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda.
    Zakumumpa H; Tumwine C; Milliam K; Spicer N
    BMC Health Serv Res; 2021 Jul; 21(1):692. PubMed ID: 34256756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of the US President's Emergency Plan for AIDS Relief's Funding With Prevention of Mother-to-Child Transmission of HIV in Kenya.
    Barnhart DA; Tsikhutsu I; Kirui D; Sawe F; Muli J; Sugut W; Abboud N; Birx D; Hamm T; Coakley P; Hickey PW; Wolfman V; Lee E; Spiegelman D
    JAMA Netw Open; 2019 Sep; 2(9):e1911318. PubMed ID: 31517966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda.
    Bajunirwe F; Tumwebaze F; Abongomera G; Akakimpa D; Kityo C; Mugyenyi PN
    BMC Res Notes; 2016 Apr; 9():217. PubMed ID: 27074947
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of long-term antiretroviral therapy in reproductive-age women in sub-Saharan Africa (the PEPFAR PROMOTE study): a multi-country observational cohort study.
    Taha TE; Yende-Zuma N; Brummel SS; Stranix-Chibanda L; Wambuzi Ogwang L; Dadabhai S; Chinula L; Nyati MM; Hanley S; Makanani B; Chipato T; Atuhaire P; Aizire J; Fowler MG
    Lancet HIV; 2022 Jun; 9(6):e394-e403. PubMed ID: 35489365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. "The number of clients is increasing but the supplies are reducing": provider strategies for responding to chronic antiretroviral (ARV) medicines stock-outs in resource-limited settings: a qualitative study from Uganda.
    Zakumumpa H; Kiweewa FM; Khuluza F; Kitutu FE
    BMC Health Serv Res; 2019 May; 19(1):312. PubMed ID: 31092245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.